Uganda-based drug maker Cipla Quality Chemicals (Cipla QCIL) has announced the unit price for its initial public offering (IPO).

CiplaQCIL is floating 657 million shares at 256.5 Uganda shillings ($0.07) per share after the Uganda Capital Markets Authority approved its prospectus.

Total estimated gross proceeds of the offering are approximately $46 million.

The offer is open to the general public until August 24 and listed on the Uganda Stock Exchange, scheduled for September 24.